Ocular allergy: the Third Annual Thygeson Lecture, presented at the Ocular Microbiology and Immunology Group Meeting, October 25, 1997.
Smolin
G
G
Proctor Foundation, San Francisco, and University of California at San Francisco, USA.
D000287:Administration, Topical; D000485:Allergens / Q000009:adverse effects*; D018926:Anti-Allergic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003233:Conjunctivitis, Allergic / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D004359:Drug Therapy, Combination; D006801:Humans; D007111:Immunity, Cellular; D007073:Immunoglobulin E / Q000276:immunology; D014662:Vasoconstrictor Agents / Q000008:administration & dosage / Q000627:therapeutic use
D000485:Allergens; D018926:Anti-Allergic Agents; D014662:Vasoconstrictor Agents; D007073:Immunoglobulin E